Portfolio Company Presentation Series – Formo Bio

Agronomics Limited

16 September 2024

 

RNS Reach

16th September 2024

Agronomics Limited

("Agronomics" or the "Company")

Portfolio Company Presentation Series - Formo Bio GmbH

Agronomics (LSE: ANIC), a leading listed company in the field of cellular agriculture, is pleased to announce that it will be hosting the fourth presentation in its Capital Markets portfolio series.

The Agronomics' Capital Markets Investor Presentation Series comprises individual presentations from industry-leading companies in the cell culture and precision fermentation sector within the Agronomics portfolio. For each presentation, the portfolio company's management team will provide in-depth insights into the purpose, market demand, technical milestones, and growth strategy of the company, together with a Question & Answer session at the end of the presentation. Agronomics expects to hold, on average, a presentation every eight weeks.

The presentation will include the senior management team at Formo Bio GmbH ("Formo") on 26  September 2024 at 15:00 BST. Attendees are able to register for the event using the following link: https://us02web.zoom.us/webinar/register/WN_xiVZVFEnTnaQMeb6rIAjmg#/registration.

After registering, attendees will receive a confirmation email containing information about joining the webinar.

Formo is an innovative European fermentation startup that is redefining the future of cheese. Founded in 2019, with locations in Berlin and Frankfurt, Formo develops animal-free alternatives that combine taste and sustainability. Using state-of-the-art fermentation technology, Formo creates cheese alternatives that taste great and contribute positively to the environment. Learn more at https://formo.bio/.

Formo recently announced that it has successfully raised US$ 61 million in its Series B funding round which will help the company achieve key milestones, including international expansion, diversifying the product range, driving revenue growth and achieving net profitability by 2027. Formo will also invest in its technology platform to accelerate the commercialisation of animal-free casein products, which will expand the portfolio to include hard cheeses, opening further opportunities in the market.

In addition to the new financing, Formo announced that its first two cheese products Frischhain and Camembritz, are now available at over 2,000 REWE, BILLA and METRO stores across Germany and Austria.

About Agronomics

Agronomics is a leading London-listed company focussing on investment opportunities within the field of cellular agriculture. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

For further information please contact:

Agronomics Limited	Beaumont Cornish Limited	Canaccord Genuity Limited	Cavendish Capital Markets Limited	Peterhouse Capital Limited	SEC Newgate
The Company	Nomad	Joint Broker	Joint Broker	Joint Broker	Public Relations
Jim Mellon Denham Eke	Roland Cornish James Biddle	Andrew Potts Harry Pardoe Alex Aylen (Head of Equities)	Giles Balleny Michael Johnson Charlie Combe	Lucy Williams Charles Goodfellow	Bob Huxford Anthony Hughes
[phone] [e-mail]	[phone]	[phone]	[phone]	[phone]	[e-mail]

Nominated Adviser

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

 

END